|
|
FDADocs 5/9/2008 | 0 (0) | 85 | 0 | 0 | English
DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCHFDA CLINICAL BRIEFING DOCUMENT FOR THE ONCOLOGIC DRUG ADVISORY ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 50 | 0 | 0 | English
IsDEPARTMENT OF HEALTH & HUMAN SERVICESFED 7 2007Sidney Wolfe , M .D . Elizabeth Barbehenn, Ph.D. Public Citizen Health Research Group 1600 20'" Street, NW Washington, ... ... more>>
FDADocs 5/9/2008 | 0 (0) | 23 | 0 | 0 | English
FDA UPDATEMelissa Greenwald, M.D. Division of Human Tissues OCTGT, CBER, FDAAATB 31st Annual Meeting 18 September 2007 Boston, MAFDA Update??? ??? ??? ??? ??? Registration and Listing ... more>>
FDADocs 5/9/2008 | 0 (0) | 39 | 1 | 0 | English
ched DocuI. Assay of Alka-Plex Mix and finished Granules 2. FDA Response I 3. FDA response letter ardi ardin S status of ingredient. 14. 19s Patent # 6143221 Agglomerating and drying 5. US ... more>>
FDADocs 5/9/2008 | 0 (0) | 27 | 0 | 0 | English
NDA 20-720/S-012 NDA 20-720/S-014 Parke-Davis Pharmaceutical Research Attention: Ms. Mary E. Taylor, M.P.H. Director, Worldwide Regulatory Affairs 2800 Plymouth Road Ann Arbor, MI ... ... more>>
FDADocs 5/8/2008 | 0 (0) | 18 | 0 | 0 | English
Perspectives on Supplying Attenuation Grades of Titanium Dioxide and Zinc Oxide for Sunscreen ApplicationsDavid Schlossman, Yun Shao, Ph.D., Pascal Delrieu, Ph.D., Kobo Products ... ... more>>
FDADocs 5/9/2008 | 0 (0) | 34 | 0 | 0 | English
???FDA Regulatory Pathway???2nd Annual FDA and the Changing Paradigm for Tissue Regulation... Answers ??? ??? ??? ??? ??????361??? HCT/Ps??? No pre-market review--no application to FDA is ... more>>
FDADocs 5/9/2008 | 0 (0) | 26 | 0 | 0 | English
Review and Evaluation of Clinical Data NDA #21-336Sponsor: Drug: Proposed Indication: Material Submitted: Correspondence Date: Date Received: Related NDA:Somerset Pharmaceu... ... more>>
FDADocs 5/9/2008 | 0 (0) | 36 | 2 | 0 | English
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation Research Office of Pharmacoepidemiology and Statistical Science Office of Biost... ... more>>
FDADocs 5/9/2008 | 0 (0) | 37 | 1 | 0 | English
DIVISION OF DRUG ONCOLOGY PRODUCTS Briefing Document for Oncology Drug Advisory Committee NDA: Applicant: Established Drug Name: 21-986, N-000 Bristol-Myers Squibb Dasatinib (BMS-3... ... more>>
FDADocs 5/9/2008 | 0 (0) | 23 | 1 | 0 | English
DIVISION OF DRUG ONCOLOGY PRODUCTS Briefing Document for Oncology Drug Advisory Committee NDA: Applicant: Established Drug Name: 21-986, N-000 Bristol-Myers Squibb Dasatinib (BMS-3... ... more>>
FDADocs 5/9/2008 | 0 (0) | 25 | 0 | 0 | English
MEMORANDUMDEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCHDATE: FROM:October 12, 2005 ... ... more>>
FDADocs 5/9/2008 | 0 (0) | 28 | 0 | 0 | English
Statistical Review/NDA21-743/SE1-003 U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Office of Pharmacoepidemiolog... ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 21 | 0 | 0 | English
GovernmentDocs 5/5/2008 | 0 (0) | 28 | 0 | 0 | English
| | | |
| results / page 15/25/50 |
Page: 8 of 33
|
...8...
|
|